Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana
Frontiers in Synaptic Neuroscience · 14.03.2022 · 14
DOI: 10.3389/fnsyn.2022.760330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Synaptic Neuroscience, online erschienen am 14.03.2022. Verfasst von Riley T Paulsen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Basic Biomedical Sciences, Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota, Vermillion, SD…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Science Foundation, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Endocannabinoids are lipid neuromodulators that are synthesized on demand and primarily signal in a retrograde manner to elicit depression of excitatory and inhibitory synapses. Despite the considerable interest in their potential analgesic effects, there is evidence that endocannabinoids can have both pro-nociceptive and anti-nociceptive effects. The mechanisms contributing to the opposing effects of endocannabinoids in nociception need to be better understood before cannabinoid-based therapies can be effectively utilized to treat pain. Using the medicinal leech, Hirudo verbana , this work investigates whether endocannabinoids modulate tonic inhibition onto non-nociceptive afferents. In voltage clamp recordings, we analyzed changes in the tonic inhibition in pressure-sensitive (P) cells following pre-treatment with endocannabinoids, 2-arachidonoylglycerol (2-AG) or anandamide (AEA). We also tested whether high frequency stimulation (HFS) of nociceptive (N) cells could also modulate tonic inhibition. Both endocannabinoid application and N cell HFS depressed tonic inhibition in the P cell. Depression of tonic inhibition by N cell HFS was blocked by SB 366791 (a TRPV1 inhibitor). SB 366791 also prevented 2-AG-and AEA-induced depression of tonic inhibition. HFS-induced depression was not blocked by tetrahydrolipstatin (THL), which prevents 2-AG synthesis, nor AM 251 (a CB1 receptor inverse agonist). These results illustrate a novel activity-dependent modulation of tonic GABA currents that is mediated by endocannabinoid signaling and is likely to play an important role in sensitization of non-nociceptive afferent pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Basic Biomedical Sciences, Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota, Vermillion, SD, United States.
Förderung
- NINDS NIH HHS
- National Science Foundation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Paulsen, R. T., & Burrell, B. D. (2022). Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana. Frontiers in Synaptic Neuroscience, 14. https://doi.org/10.3389/fnsyn.2022.760330
Vancouver
Paulsen RT, Burrell BD. Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana. Frontiers in Synaptic Neuroscience. 2022;14. doi:10.3389/fnsyn.2022.760330
BibTeX
@article{Paulsen2022,
author = {Paulsen, Riley T and Burrell, Brian D},
title = {Activity-Dependent Modulation of Tonic GABA Currents by Endocannabinoids in Hirudo verbana},
journal = {Frontiers in Synaptic Neuroscience},
year = {2022},
volume = {14},
doi = {10.3389/fnsyn.2022.760330}
}
EUVIMED